DANIEL CLAYTON: Open Payments
NPI 1629046586 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 33 payments from 11 companies in 2025. Trend: 2023 $979 · 2024 $827 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 10 | $202 |
| PFIZER INC. | 5 | $95 |
| Collegium Pharmaceutical, Inc. | 4 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $48 |
| ABBVIE INC. | 3 | $47 |
| Saluda Medical Americas, Inc. | 1 | $42 |
| Abbott Laboratories | 2 | $40 |
| Valinor Pharma, LLC | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
Products named: NURTEC ODT, Belbuca, Intracept, General - Pain Management, RELISTOR, WaveWriter Alpha Prime 16, Evoke, Clinical Trial Product.
Industry payments across LA — which companies pay providers there.
